Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesJun 3, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 28, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 26, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 26, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 19, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 19, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 19, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 19, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 19, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 19, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 19, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 12, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 12, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 12, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 12, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 12, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 12, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 8, 2015View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionMay 5, 2015View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
4Statement of changes in beneficial ownership of securitiesMay 5, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 5, 2015View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventApr 30, 2015View HTMLDownload DOCDownload PDFDownload XLS
ARSAn annual report to security holders.Apr 27, 2015View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-125      126-127

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information